Nusinersen May Stabilize Disease Status in SMA Types 2 and 3

Treatment with nusinersen may decrease disease progression in pediatric patients who are nonambulatory with spinal muscular atrophy types 2 and 3.

Related Keywords

Switzerland , Germany , Austria , , Orphanet Journal , Hammersmith Functional Motor Scale Expanded , Revised Upper Limb Module ,